Contact Us marketing@medicilon.com
Medicilon Logo
|
search icon search icon contact icon menu icon
Medicilon Logo
|
search icon close search icon contact icon menu icon
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
Medicilon's News information
News information

Custom Antibody Development Services

2016-10-19
|
Page View:

We provide a complete range of custom monoclonal antibody development services, from antigen design and production to humanized antibodies. We will use an antigen that you supply, or we can produce it for you, either as a recombinant protein or a chemically synthesized peptide.

Medicilon's antibody development technical service discount covers the full line of ADA antibody development technical services and druggable antibody development technical services. The 20% off discount applies to the completion of ADA rabbit polyclonal antibody development, ADA mouse hybridoma monoclonal antibody development, phage display rabbit monoclonal antibody development services, mouse monoclonal antibody development technical services, mouse/rabbit single B cell antibody development technical services, etc.

antibody development services

Some of the Stand-Alone Services We Provide Include

Antigen Design and Production

Immunizations

Hybridoma Development

Hybridoma Cell Culturing and Antibody Purification

Antibody cDNA Sequencing

Antibody Isotype Switching

Antibody Chimerisation

Transient Expression of Monoclonal Antibodies

Program Features

Capabilities to develop fully human MAbs using OMT’s transgenic OmniRat™ and ffOmniMouse™ technologies

Human MAb phage display technology platforms

Custom phage display library generation

Exceptionally high cell fusion rates for the creation of hybridomas

High-throughput analysis of MAb pools

A wide array of in-vitro and in-vivo antibody screening and characterization assays

AAALAC-accredited animal facility

Reliable, cost-effective solutions with global access to the world’s fastest-growing healthcare markets

Proven target-to-lead capabilities

Full range of services from discovery to commercialization

World-class advanced hybridoma technology platforms for therapeutic MAb discovery

State-of-the-art laboratory and manufacturing facilities (GMP and non-GMP)

Our Antibody Competitive Advantages

Rapid Development of Antibodies

High Content mAB Development

High-Affinity Antibody Development

High Success Rate

mAB Development to Difficult and Rare Epitopes

High Throughput Robotic Automation

Depth Discussion and Understanding of Customer Needs

Highly Trained and Experienced Staff

Comprehensive Services

It is always early enough to start planning for antibody development. A carefully planned antibody development strategy almost always provides good results. Before starting antigen preparation, you must have a well-defined screening strategy. Please start talking to us when you anticipate the need to develop antibodies for your target. We will work with you to create the antibody reagent you need.

Scientists at our R&D department are continually improving our state-of-the-art proprietary technology to achieve the cost-effective development of quality antibodies to serve you better.

Contact Us 

Email: marketing@medicilon.com

Tel : +86 021 58591500

Tips: Above is part of antibody development services, monoclonal antibody services, and antibody development costs. You can also CONTACT US with any question or inquiry you may have. We will be happy to discuss your needs and design an appropriate action plan.


Related Articles:

Medicilon Assists | China's First CD19×CD3×CD28 Trispecific Antibody Obtained FDA Implicit Approval

Medicilon Assistant| Jimincare's lgE Antibody Drug JYB1904 has been Approved for Clinical Trials

Medicilon assisted Bio-Thera's bispecific neutralizing antibody drug for injection BAT2022 for the treatment of new coronary pneumonia was approved for clinical use

Return
Relevant newsRelevant news